Cargando…
P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429440/ http://dx.doi.org/10.1097/01.HS9.0000846132.33920.32 |
| _version_ | 1784779443457228800 |
|---|---|
| author | Kulasekararaj, A. Brodsky, R. Griffin, M. Kulagin, A. Ogawa, M. Wang, J. Mujeebuddin, A. Nishimura, J.-I. Peffault de Latour, R. Szer, J. Lee, J. W. |
| author_facet | Kulasekararaj, A. Brodsky, R. Griffin, M. Kulagin, A. Ogawa, M. Wang, J. Mujeebuddin, A. Nishimura, J.-I. Peffault de Latour, R. Szer, J. Lee, J. W. |
| author_sort | Kulasekararaj, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94294402022-08-31 P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS Kulasekararaj, A. Brodsky, R. Griffin, M. Kulagin, A. Ogawa, M. Wang, J. Mujeebuddin, A. Nishimura, J.-I. Peffault de Latour, R. Szer, J. Lee, J. W. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429440/ http://dx.doi.org/10.1097/01.HS9.0000846132.33920.32 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kulasekararaj, A. Brodsky, R. Griffin, M. Kulagin, A. Ogawa, M. Wang, J. Mujeebuddin, A. Nishimura, J.-I. Peffault de Latour, R. Szer, J. Lee, J. W. P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title | P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title_full | P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title_fullStr | P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title_full_unstemmed | P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title_short | P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS |
| title_sort | p812: long-term complement inhibition and survival outcomes in patients with paroxysmal nocturnal hemoglobinuria: an interim analysis of the ravulizumab clinical trials |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429440/ http://dx.doi.org/10.1097/01.HS9.0000846132.33920.32 |
| work_keys_str_mv | AT kulasekararaja p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT brodskyr p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT griffinm p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT kulagina p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT ogawam p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT wangj p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT mujeebuddina p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT nishimuraji p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT peffaultdelatourr p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT szerj p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials AT leejw p812longtermcomplementinhibitionandsurvivaloutcomesinpatientswithparoxysmalnocturnalhemoglobinuriaaninterimanalysisoftheravulizumabclinicaltrials |